|
Volumn 17, Issue 4, 2002, Pages 187-190
|
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia
|
Author keywords
CYP2D6; Fluoxetine; Genotype; Hyponatraemia; Norfluoxetine; Paroxetine
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENDROFLUMETHIAZIDE;
CHLORPROMAZINE;
CILAZAPRIL;
CYTOCHROME P450 2D6;
DICLOFENAC;
DOXEPIN;
ENALAPRIL;
FLUOXETINE;
FUROSEMIDE;
GENOMIC DNA;
NORFLUOXETINE;
PAROXETINE;
QUINAPRIL;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
AGED;
ALLELE;
ARTICLE;
BIOASSAY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DEPRESSION;
DNA DETERMINATION;
DRUG BLOOD LEVEL;
DRUG METABOLISM;
GENETIC ANALYSIS;
GENETIC LINKAGE;
GENOTYPE;
HUMAN;
HYPONATREMIA;
HYPOTHESIS;
POPULATION RESEARCH;
PREDICTION;
PRIORITY JOURNAL;
PUBLICATION;
REFERENCE VALUE;
STATISTICAL ANALYSIS;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
FEMALE;
GENETICS;
MALE;
METABOLISM;
MIDDLE AGED;
RISK FACTOR;
AGED;
AGED, 80 AND OVER;
CYTOCHROME P-450 CYP2D6;
DEPRESSIVE DISORDER;
FEMALE;
FLUOXETINE;
GENOTYPE;
HUMAN;
HYPONATREMIA;
MALE;
MIDDLE AGE;
PAROXETINE;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
SUPPORT, NON-U.S. GOV'T;
HUMANS;
MIDDLE AGED;
|
EID: 0035989059
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/hup.394 Document Type: Article |
Times cited : (28)
|
References (16)
|